GlassScriptPhysician profile
Gregory M Houck
NPI 1487625885
$1,695.55
in general payments reported to CMS, 2019-2025
18 companies · $299 in 2025
The $299 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $73.84 · 2021: $61.17 · 2022: $276 · 2023: $397 · 2024: $427 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,123.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $509.91 | 2021-2025 | Cygnus Dual, Puraply, Puraply Wound Matrix |
| Galderma Laboratories, L.P. | $179.41 | 2020-2025 | Dysport, Nemluvio |
| Abbvie INC. | $147.13 | 2023-2025 | |
| Pfizer INC. | $143.64 | 2019-2024 | |
| Aclaris Therapeutics, INC. | $125.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $122.65 | 2020-2025 | |
| Genzyme Corporation | $113.08 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $103.47 | 2022-2024 | Keytruda |
| Dermavant Sciences, INC. | $38.49 | 2022 | |
| Almirall LLC | $29.64 | 2024 | Seysara |
| Kerecis Limited | $29.41 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ucb, INC. | $29.15 | 2023 | Bimzelx |
| Mayne Pharma Commercial LLC | $24.09 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $22.69 | 2022 | |
| Amgen INC. | $21.83 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $21.83 | 2022 | |
| Sun Pharmaceutical Industries INC. | $20.64 | 2025 | |
| Leo Pharma INC. | $13.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Houck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.